FINNENCE ▪ THE WIRE FILE
THE WIRE · № 70910
News■ Unclear/unknown
Keenova Announces New Presentations at the Sexual Medicine Society of North America Annual Meeting
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 11:30 UTC
LAST UPDATE2026-10-08 11:30 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Conference presentations on men's health data are scientific disclosure, not financial guidance.
Clinical conference data, minimal market impact
CATALYST TO WATCH
Peer-reviewed publication or partnership
MAIN RISK
No commercial timeline disclosed
FULL DISPATCH
DUBLIN, Oct. 8, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that it will share data and insights related to men's health during three speaker presentations at the Sexual Medicine Society of North America annual meeting, taking place October 8-11, 2026. Two presentations...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
Saol Therapeutics Announces Completion of Enrollment in Pivotal Phase III BEACON Trial of SL1002 for the Treatment of Chronic Pain Related to Osteoarthritis of the Knee2026-10-08 11:30 UTC
Saol Therapeutics Announces Completion of Enrollment in Pivotal Phase III BEACON Trial of SL1002 for the Treatment of Chronic Pain Related to Osteoarthritis of the Knee2026-10-08 11:30 UTC
→CORRELATIONshares Healthcare
Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform2026-10-08 11:30 UTC
Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform2026-10-08 11:30 UTC
→CORRELATIONshares Healthcare
Viola Davis partners with GSK to educate adults 50 and older about their shingles risk2026-10-08 11:38 UTC
Viola Davis partners with GSK to educate adults 50 and older about their shingles risk2026-10-08 11:38 UTC
→CORRELATIONshares Healthcare
Expert consensus statement highlights promise of shared medical appointments for chronic disease care2026-10-08 11:43 UTC
Expert consensus statement highlights promise of shared medical appointments for chronic disease care2026-10-08 11:43 UTC
→CORRELATIONshares Healthcare
Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies2026-10-08 11:45 UTC
Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies2026-10-08 11:45 UTC
→CORRELATIONshares Healthcare
Cyrano Therapeutics' Phase 2 FLAVOR Trial Selected to Open 72nd Annual Meeting of the American Rhinologic Society (ARS)2026-10-08 12:10 UTC
Cyrano Therapeutics' Phase 2 FLAVOR Trial Selected to Open 72nd Annual Meeting of the American Rhinologic Society (ARS)2026-10-08 12:10 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.